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To explore the effect of beta-adrenergic blockade on low heart 
rate-related (mental stress) ischemia, 19 patients with coronary 
artery disease were randomized into a double-blind crossover trial 
of metoprolol, 100 mg twice daily, and underwent serial mental 
stress/bicycle exercise studies. Mental stress-induced wall motion 
abnormalities occurred at a lower heart rate than exercise-
induced wall motion abnormalities during placebo administration 
(81 ± 16 vs. 123 ± 20 beats/min, p < 0.05). Metoprolol reduced 
the mean magnitude of exercise-induced wall motion abnormali-
ties (2.8 ± 2.0 vs. 1.6 ± 2.4, p = 0.003); improvement was related 
to the magnitude of hemodynamic beta-blockade effect. Meto-
prolol did not significantly reduce the mean magnitude of mental 
stress-induced wall motion abnormalities (3.0 ± 2.2 vs. 2.6 ± 2.2), 
although individual responses predominantly either improved 
(50%) or worsened (29%). 
Unlike exercise, the magnitude of hemodynamic beta-blockade 
Modeled mental stress in the laboratory is a potent stimulus 
of transient myocardial ischemia in patients with coronary 
artery disease (1). Mental tasks designed to promote frustra-
tion or specific emotions frequently induce ischemic ventric-
ular dysfunction, often of a magnitude similar to that induced 
by strenuous exercise. Because most ischemic episodes 
induced by mental stress occur at relatively low heart rate 
elevations compared with those induced by exercise, mental 
stress and exercise-induced ischemia may have different 
pathophysiologic mechanisms. Although ischemia occurring 
at relatively low heart rate elevations has typically been 
attributed to a decrease in myocardial oxygen supply, our 
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did not predict mental stress response and metoprolol did not 
block mental stress-induced blood pressure elevations. Patients 
with abolition of exercise-induced ischemia were more likely to 
have reduction of mental stress-induced ischemia. Patients whose 
ischemia worsened with metoprolol during mental stress had more 
easily inducible ischemia, as assessed by exercise-induced placebo 
wall motion abnormality, chest pain and prior myocardial infarc-
tion. Beta-blockade was associated with a lowering of ischemia-
related hemodynamic thresholds compared with placebo. 
These results suggest that beta-blockade has a variable effect 
on low heart rate-related ischemia that may be due to a lack of 
effect on mental stress-induced blood pressure elevation in pa-
tients with easily induced ischemia or to effects on coronary 
vasomotor tone, or both. 
(J Am Coll CardioI1991;17:1388-95) 
prior work demonstrates that increased demand also plays 
an important role in the genesis of low heart rate-related 
ischemia. Specifically, we 0,2) and others (3) have found 
substantial blood pressure elevations during mental stress-
induced ischemia. 
Beta-adrenergic blockade is an effective anti-ischemic 
therapy, predominantly working by decreasing myocardial 
oxygen demand through reductions in heart rate and blood 
pressure (4). Thus, an intervention designed to decrease 
cardiac demand may modify the ischemic response to mental 
stress. Additionally, studies of pharmacologic agents that 
alter cardiac demand could enhance our understanding of the 
contributory pathophysiologic mechanisms in the genesis of 
low heart rate-related ischemia. Thus, we undertook a study 
to evaluate the comparative effects of a cardioselective 
beta-adrenergic blocker (metoprolol) on mental stress-
induced and exercise-induced ischemia. 
Methods 
Selection of patients. Thirty patients who fulfilled the 
following criteria were initially recruited for participation 
into our study: a history of cardiac chest pain; and a positive 
treadmill exercise electrocardiographic stress test, defined 
as ::::1.0 mm horizontal or downsloping or::::1.5 mm upslop-
ing ST segment depression, measured at 0.08 ms after the J 
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point. Patients with mild to moderate hypertension were 
preferentially selected for this study, according to a concom-
itant protocol (5). Nineteen of the 30 patients had clinical 
coronary artery disease and formed the study population. 
They included patients with either documented coronary 
disease (10 patients) or a high (2':90%) Bayesian probability 
of coronary disease (9 patients) based on clinical and radio-
nuclide exercise test variables (6). The rationale for the use 
of serial Bayesian analysis as an alternative referent stan-
dard has been described (7). 
After an initial visit and maximal or symptom-limited 
treadmill exercise testing, patients were randomized into a 
double-blind crossover trial involving 3 weeks each of pla-
cebo or metoprolol, 100 mg twice daily. Patients underwent 
the mental stress/bicycle exercise radionuclide ventriculo-
graphic laboratory stress studies, described later, at the end 
of each 3 week period. Each subject signed an informed 
consent form approved by our Human Subjects Committee 
on March 1, 1986. 
Laboratory study protocol. Patients were studied in a 
fasting state at approximately the same time of the day (early 
afternoon) for each testing period. Each subject received an 
injection of technetium-99m in vitro labeled red blood cells. 
Mental stress testing always preceded the exercise testing; 
the two test protocols were separated by a 15 to 30 min 
relaxation period. After an initial relaxation period of 10 min, 
the patients performed the mental tasks sequentially, with 
each task lasting 3 to 5 min, separated by 7 min rest periods. 
A 2 min radionuclide ventriculogram was obtained before 
and after the initial 10 min rest period, during each mental 
task and during the final 2 min of each 7 min rest period. 
Task order was counterbalanced between the first and 
second testing dates. using two order sequences: 1) arith-
metic, Stroop word and public speaking; and 2) Stroop word, 
public speaking and arithmetic. Patients with an odd study 
identification number were assigned task order sequence I. 
To minimize habituation to the mental stressors, an alternate 
mental stress protocol of similar but different tasks was used 
during the second study period. These alternate tasks were 
always performed for the second mental stress period. 
Mental tasks. A series of three paired mental tasks were 
used. The three tasks, which we used in a previous study 0). 
lasted 3 to 5 min each and are described briefly: 
1. Mental arithmetic. Patients were instructed to sub-
tract serial 7s from a 4 digit number as quickly and as 
accurately as possible during the first study. The "alternate" 
task was to sum the figures of a 4 digit number, subtract that 
sum from the original number and serially repeat the pro-
cess. 
2. Stroop color word task. Patients were shown a series 
of slides in rapid series, displaying the names of colors (e.g .. 
blue) written in a different color (e.g., red). Patients were to 
pick the color of the ink, not the color word. The "alternate" 
task used colored slides different from the first set. Addition-
ally, a tape recording of rapidly spoken, random color names 
was played during the second testing period to distract the 
patient. 
3. Simulated public speaking. Patients were asked to 
give a 5 min speech in front of two observers regarding 
personal faults or undesirable habits. The "alternate" task 
was to describe a stressful or embarrassing event in detail, in 
front of a video recorder camera. 
Exercise protocol. Exercise testing was performed using 
an upright bicycle ergometer, with graded work load in-
creases of 200 kilopond-meters (2,000 J)/min every 3 min. 
Patients exercised to the point of exhaustion, marked chest 
pain. marked hypertension or significant arrhythmia. Radio-
nuclide images were obtained in the upright exercise position 
immediately before the onset of exercise, during the last 
2 min of each 3 min stage and immediately after exercise. 
Data acquisition. During mental stress testing. subjects 
were positioned with the upper torso semi-erect, at approx-
imately a 45° angle; during bicycle exercise, the subjects 
were upright. R wave-synchronized, multigated equilibrium 
radionuclide ventriculography was performed at 20 frames/ 
cardiac cycle with use of a mobile gamma camera equipped 
with a 0.25 in. (0.64 cm) sodium iodide crystal and an 
all-purpose collimator (8). Imaging was performed with the 
camera positioned in the left anterior oblique angle that best 
separated the left and right ventricles. Two-minute imaging 
resulted in approximately 100,000 counts/frame. Cardiac 
rhythm, 12 lead ST segments and heart rate were continu-
ously monitored. During mental tasks, blood pressure was 
monitored at 2 min intervals with use of an automated cuff; 
during exercise. it was monitored at 3 min intervals with use 
of a standard mercury sphygmomanometer. 
Data interpretation. Left ventricular ejection fraction and 
segmental wall motion were determined for each rest condi-
tion and intervention. A computer operator who did not 
know the clinical data determined ejection fraction values, 
using light-pen assignment of end-diastolic, end-systolic and 
background regions of interest (8). Segmental wall motion 
was assessed visually with use of a continuous loop video 
display of the images after spatial and temporal smoothing of 
the data. The video format involved an eight-image display 
in which the first two images were initial rest images. The 
subsequent six images were three pairs of alternating pre-
task and during-task images, with the control images preced-
ing each task image. Control images were also placed 
randomly in the during-task image positions for quality 
control evaluation. Wall motion was scored independently 
by two experienced observers. Discrepant studies were 
scored a third time, without knowledge of previous findings, 
by the same two observers who read concurrently and 
scored according to consensus. The mental task studies were 
interpreted before the exercise studies. 
For wall motion scoring, the left ventricle was separated 
into five segments (two septal, one apical and two postero-
lateral), each graded on a 5 point scale: 3 (normal wall 
motion), 2 (mild hypokinesia), 1 (moderate to severe hypo-
kinesia), 0 (akinesia), and -1 (dyskinesia) (8). Segmental 
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Table 1. Clinical Characteristics of 19 Patients 
Pt. Age (yr)1 Prior Prior Coronary Prior CAD Chest Pain ECG 
No. Gender MI Angio CABG Prob (%) Frequency HTN LVH 
I 59/M 93 :sl/wk + 
2 50/M 92 :s I/wk 
51/M + >l/wk + 
4 59/M 98 >1/wk + 
5 771M + + >1/wk + 
6 66/F + + 2:: 1/day + 
7 57/M 99 >l/day 
8 55/M + > 1/day 
9 58/M 96 >1/wk + 
10 67/M + + >lIwk 
II 61/M + + 2:: 1/day + + 
12 68/M 99 :slIwk + 
13 65/M 99 >lIwk + 
14 56/F + >l/wk + + 
15 52/M + + :s I/wk + 
16 60/M 95 >lIwk + 
17 63/M + 2::lIday 
18 6 11M 99 2::l/day + 
19 6 11M + >l/wk + 
Angio = angiography; CABG = coronary artery bypass grafting; CAD Prob = posttest probability of coronary artery disease; ECG LVH 
electrocardiographic left ventricular hypertrophy; F = female; HTN = history of hypertension; M = male; MI = myocardial infarction; + = present. 
wall motion was considered to have worsened when the peak 
score decreased 1 from both the initial baseline score and the 
immediately preceding rest score. The reliability of wall 
motion scoring in our laboratory is excellent (1). Among 84 
randomly selected images (420 segments) read twice by our 
observers from 33 patient studies in a prior analysis, agree-
ment was 88% (weighted kappa, mean [± SE], 0.86 ± 0.02). 
We have also demonstrated (1) that the presence and loca-
tion of these wall motion abnormalities during mental stress 
correspond to significant angiographic coronary stenoses 
and reversible stress thallium defects. A summative wall 
motion worsening score was calculated by adding the mea-
sures of extent (number of wall motion segments worsening) 
and severity (number of scores an individual wall motion 
segment worsened). Evidence of inducible wall motion ab-
normality was defined as a worsened score 2: 1 during an 
exercise stage or mental task. When comparing the wall 
motion responses between metoprolol and placebo therapy, 
a net change in summative wall motion score 2:2 in either 
direction was defined as a significant change (i.e., improve-
ment or worsening) between the testing periods. A net 
change ::s 1 was defined as no change. 
Peak heart rate and blood pressure during each task and 
exercise stage were used for hemodynamic calculations. ST 
segments were measured at 0.08 ms after the J point. A net 
change of 2: 1.0 mm horizontalldownsloping or 2: 1.5 mm 
upsloping ST segment depression was considered signifi-
cant. For appropriate comparisons, metoprolol exercise 
stage work loads were matched to the highest stage work 
load achieved during placebo exercise. 
Statistical analysis. Data were expressed as either mean 
values ± SD or as proportions. Comparisons of mean data 
for patients on placebo and metoprolol were performed using 
the paired t test. Comparisons of proportions were per-
formed using McNemar's test of symmetry and Fisher's 
exact test. To examine the effect of task ordering and study 
order analysis, analysis of variance with repeated measures 
was performed. In all tests a p value ::s 0.05 was considered 
significant. 
Results 
Study patients. The demographic and clinical character-
istics of the 19 patients are summarized in Table 1. They had 
an overall mean age of 60 ± 7 years and included 17 men 
(89%). All patients had a rest ejection fraction >50%. During 
placebo treatment, 15 (79%) of the 19 patients had evidence 
of an inducible wall motion abnormality at maximal bicycle 
exercise and 14 (74%) had worsening of wall motion during 
mental stress testing. 
Group effects of metoprolol on ischemic markers. A men-
tal stress wall motion abnormality occurred only among the 
patients with an exercise-induced wall motion abnormality, 
during both placebo and metoprolol treatment. Metoprolol 
did not significantly reduce the overall frequency of positive 
wall motion abnormality results during exercise (from 79% 
to 58%) or mental stress (from 74% to 64%). 
The comparative frequencies of chest pain and ST seg-
ment depression and the magnitudes of wall motion abnor-
mality and ejection fraction change with exercise and mental 
stress testing during placebo and metoprolol therapy are 
shown in Figure I. For matched work loads, metoprolol 
decreased the frequency and magnitude of all ischemic 
markers during exercise (p < 0.05 for wall motion abnormal-
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Figure 1. Frequency and magnitude of ischemic markers with 
exercise and mental stress during placebo (open bars) and me to-
prolol (closed bars) administration in 14 patients. Chest pain and ST 
segment depression (ST ~) responses are plotted as percent posi-
tive (+) on the left; the magnitude of induced wall motion abnor-
mality (WMA) and left ventricular ejection fraction change (EF %) 
on the right * = p < 0.05, comparing metoprolol and placebo. 
ity and ejection fraction change), Of the 15 patients with 
exercise-induced ischemia on placebo, 9 had improvement in 
wall motion abnormality during metoprolol therapy,S had no 
change and 1 patient could not be matched because of 
missing metoprolol exercise stage radionuc1ide data, No 
patient had worsening of wall motion during metoprolol 
therapy. During placebo treatment, the mean magnitude of 
wall motion abnormality during mental stress was compara-
ble to that during exercise (Fig. 1). This mean score was not 
significantly decreased by metoprolol, but individual subject 
responses varied substantially. Of the 14 patients with ab-
normal placebo mental stress test results, 7 had improve-
ment in wall motion abnormality, 3 had no change and 4 had 
worsening with metoprolol. The subgroup without improve-
ment (the seven patients with either no change or worsening) 
tended to be functionally sicker, as evidenced by a signifi-
cantly greater magnitude of exercise-induced wall motion 
abnormality during placebo administration (3.9 ± 2.3 vs. 
1.7 ± 0.8, p < 0.05), a higherfrequency of prior myocardial 
infarction (71% vs. 0%, p < 0.05) and a trend toward more 
frequent chest pain (43% vs. 0%, p = 0.19) compared with 
findings in the subgroup of seven patients who had improved 
wall motion abnormality. 
We further evaluated the mental stress test response 
among the 14 patients with both mental stress- and exercise-
induced ischemia as it related to the success of metoprolol in 
abolishing exercise-induced wall motion abnormality. Com-
plete abolition of exercise wall motion abnormalities oc-
curred in 5 (38%) of the 14 patients. Of the nine patients with 
residual wall motion abnormality on exercise during meto-
prolol therapy, only two (25%) had improvement in mental 
stress wall motion scores with metoprolol. In contrast, four 
(80%) of the five patients with abolition of exercise-induced 
wall motion abnormality during metoprolol treatment had 
improvement in mental stress-induced wall motion abnor-
mality (p = 0.10). 
Hemodynamic effects. The group effects of metoprolol 
treatment on hemodynamic responses during exercise and 
mental stress are shown in Figure 2. Beta-blockade signifi-
cantly reduced the mean values for rest and peak heart rate 
and rate-pressure product and peak arterial blood pressure 
during exercise. Metoprolol also reduced the mean rest and 
peak heart rate and the response of rate-pressure product to 
mental stress. However, there was no significant reduction 
in the peak systolic or diastolic blood pressure response to 
mental stress during metoprolol. 
We further evaluated the hemodynamic thresholds for the 
onset of the ischemic markers during exercise and mental 
stress. Mental stress-induced wall motion abnormalities oc-
curred at a lower heart rate than did exercise-induced wall 
motion abnormalities during placebo (81 ± 16 vs. 123 ± 
20 beats/min, p < 0.05). Metoprolol reduced the mean heart 
rate threshold at which exercise-induced ST segment depres-
sion first occurred from 113 ± IS to 97 ± IS beats/min (p < 
0.05). The comparative hemodynamic thresholds associated 
with the onset of wall motion abnormalities during exercise 
and mental stress are shown in Table 2. The threshold for 
wall motion abnormality-related heart rate (p < 0.05 for 
exercise and mental stress) and rate-pressure product (p < 
0.05 for exercise) was lower with metoprolol than with 
placebo. 
Hemodynamic analyses of the subgroups with improved 
and unimproved wall motion abnormalities during exercise 
and mental stress are shown in Figure 3. Compared with the 
nine patients whose condition during exercise improved on 
metoprolol therapy, the patients without such improvement 
tended to demonstrate less beta-blockade effect, as indicated 
by smaller metoprolol-associated reductions in heart rate, 
systolic blood pressure and rate-pressure product responses 
during exercise. In contrast, during mental stress testing 
there was no apparent difference between the improved and 
unimproved groups in any of the calculated hemodynamic 
responses. 
Task and study order analysis. With placebo and with 
metoprolol administration, wall motion abnormalities were 
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Figure 2. Effect of metoprolol on group hemodynamic variables 
during exercise and mental stress at rest and at peak response in 19 
patients. Mean measurements and SD for heart rate (HR), systolic 
and diastolic blood pressure (SBP, DBP) and rate-pressure product 
(HR x SBP) are shown. The measurements obtained during placebo 
are shown as closed circles and those during metoprolol as open 
squares. * = p < 0.05, comparing metoprolol and placebo. 
most common during the speech task (Fig. 4). The frequency 
of wall motion abnormalities for the speaking task did not 
change when the task orders changed (i.e .. with the speaking 
task as the last or as the middle task) (Fig. 5). The mathe-
matics task more often caused an abnormality when it was 
performed last than when it was performed first, although 
this difference was not significant (p = 0.14). 
We also tested our results for a study order effect to 
assess whether habituation to the mental stressors could 
mask or confound our mental stress results. Specifically, we 
assessed whether the frequency of mental stress-induced 
wall motion abnormalities during the placebo and metoprolol 
phases varied according to the first study versus the second 
study period. The frequency and magnitude of mental stress-
induced wall motion abnormality was not different among 
the first study versus the second study subgroup during 
placebo (40% vs. 48% and 2.8 ± 2.0 vs. 2.3 ± 1.6, respec-
Table 2. Effect of Metoprolol on Ischemia-Related Hemodynamic 
Variables During Exercise and Mental Stress 
Exercise 
HR 
(beats/min) 
Placebo 123 ± 20 
ischemia 
Metoprolol 105 ± 19* 
ischemia 
(n = 15) 
Mental stress 
Placebo 
ischemia 
Metoprolol 
ischemia 
(n = II) 
81 ± 16 
64 ± 13* 
SBP 
(mmHg) 
197 ± 27 
185 ± 31 
180 ± 48 
185 ± 38 
DBP 
(mmHg) 
103 ± 16 
96 ± 12 
109 ± 19 
114 ± 13 
24 ± 6 
19 ± 7* 
15 ± 5 
12 ± 4 
*p < 0.05 versus placebo. DBP = diastolic blood pressure; HR = heart 
rate; HR x SBP = rate-pressure product; SBP = systolic blood pressure. 
tively, both p = NS) and metoprolol (48% vs. 30% and 2.8 ± 
1.5 vs. 2.6 ± 1.8, respectively, both p = NS). Also, 
comparative analysis of variance of mental task hemody-
namic reactivity on placebo between the first and second 
study period groups revealed no significant differences in 
heart rate, blood pressure and rate-pressure product re-
sponses (main group effects x trial interactions for task 
ordering and study ordering = NS). 
Discussion 
Our findings parallel other recent observations regarding 
the frequency and characteristics of mental stress-induced 
ischemia in patients with coronary artery disease. A high 
frequency of mental stress-induced left ventricular dysfunc-
tion in patients with coronary artery disease has been 
demonstrated with a variety of techniques, including radio-
nuclide ventriculography (1), echocardiography (3) and sta-
tionary (2) and ambulatory (9) left ventricular radionuclide 
monitoring probes. These studies and our current results 
demonstrate that mental stress-induced ischemia, compared 
with exercise-induced ischemia, occurs at relatively lower 
heart rate elevations, is more likely to be clinically and 
electrocardiographically silent and is seen primarily in pa-
tients with exercise-induced ischemia. Thus, simulated men-
tal stress in the laboratory appears to be a potent and 
reproducible causal agent for low heart rate-related myocar-
dial ischemia in patients with coronary artery disease. 
Effects of metoprolol on ischemic indexes during mental 
stress testing and exercise. Beta-adrenergic blockade had a 
beneficial effect on the magnitude of high heart rate-related 
(exercise) ischemia. Left ventricular ejection fraction was 
elevated to a greater magnitude during exercise during the 
metoprolol phase. These results are consistent with prior 
studies (10-12) showing a reduction in ischemic markers and 
enhancement of ventricular performance during exercise 
among patients with coronary disease treated with beta-
blockers. 
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Figure 3. Hemodynamic changes during exercise and mental stress 
in 14 patients receiving metoprolol. "Improved" and "unim-
proved" indicate wall motion abnormality response to metoprolol. 
Patients with improvement during exercise and mental stress (n = 9 
and 7, respectively) are shown by open bars and those without 
improvement (n = 5 and 7, respectively) by closed bars. Values are 
expressed as mean values ± SO. Changes (~) in heart rate (HR), 
systolic and diastolic blood pressure (SBP, OBP) and rate-pressure 
product (HR x SBP) are shown. 
In contrast, metoprolol demonstrated a variable effect on 
low heart rate-related (mental stress) ischemia in this study. 
Although metoprolol elicited no significant change in the 
mean wall motion abnormality value, this result is mislead-
ing because the individual responses predominantly followed 
two directions, Half of the patients had an improved score 
with metoprolol and one third had a worsened score. Pa-
tients whose wall motion abnormality improved usually 
showed abolition of exercise-induced wall motion abnormal-
ities with metoprolol. These results imply that titration of 
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Figure 4. Frequency of wall motion abnormalit~ (WMA) .(verti~al 
axis) during the different mental tasks and durmg exercise with 
placebo, and with metoprolol in 19 patients. Wall motion abnormal-
ity was induced more commonly with speech than with the other 
mental tasks. 
drug to abolition of exercise-induced ischemia may be im-
portant in the treatment of low heart rate-related ischemia, 
although this hypothesis could not be tested because patients 
were given a fixed dose of the drug. Although the hemody-
namic results during mental stress did not support a corre-
lation between the magnitude of beta-blockade effect and the 
Figure 5. Frequency of wall motion abnormality (+) with mental 
stress according to task order sequence during placebo administra-
tion. Task order I is shown by closed bars, and task order 2 by 
hatched bars. For both sequences, wall motion abnormality was 
most frequently induced by the speaking task. There was no 
statistically significant difference between the frequency of abnor-
mality induced by each task during study order 1 and that induced 
during study order 2. 
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direction of mental stress response, only further testing 
using titrated doses of metoprolol can resolve this question. 
Pathophysiologic considerations. Multiple lines of evi-
dence now demonstrate that myocardial ischemia is a com-
plex phenomenon that involves both increases in the deter-
minants of myocardial oxygen demand (1-3) and a decrease 
in coronary blood supply (13,14). Beta-blockers are believed 
to predominantly affect myocardial oxygen demand. reduc-
ing it by lowering heart rate and blood pressure (4). The 
importance of these alterations in demand on high heart 
rate-related ischemia is readily supported by the results of 
this study: reduction in ischemia with exercise during the 
metoprolol phase was associated with reductions in heart 
rate. systolic blood pressure, diastolic blood pressure and 
rate-pressure product. In contrast, the pathophysiology of 
low heart rate-related ischemia is not well understood. Blood 
pressure may increase rapidly and often markedly during 
mental stress (1-3). and a blood pressure increase accompa-
nied ischemic responses in this study. However, metoprolol 
had a minimal hemodynamic effect on mental stress-induced 
blood pressure elevation, as has been reported with other 
beta-blockers (15,16). This may explain why metoprolol was 
not as effective in reducing mental stress-induced ischemia 
compared with exercise-induced ischemia. Because patients 
without improvement during mental stress were functionally 
sicker. as evidenced by both clinical variables and the 
magnitude of exercise-induced ischemia during placebo ad-
ministration. the threshold for induction of ischemia by 
mental stress may be lower in these patients. Therefore. the 
unaffected blood pressure elevations may be proportionately 
more important in ischemia induction in this subgroup than 
in patients with less functional disease. 
Our demonstration of beta-blocker-associated reductions 
in ischemia-related hemodynamic thresholds compared with 
placebo was previously reported. McLenachan et a1. (17) 
observed a propranolol-associated reduction in ischemia-
related heart rate using ambulatory Holter ST segment 
monitoring. Steele et a1. (18) demonstrated worsened thal-
lium scintigraphic perfusion defects at matched heart rate 
and blood pressure values in patients who exercised twice. 
during propranolol and during placebo treatment. This evi-
dence raises the possibility of a beta-blockade-mediated 
limitation to coronary blood supply. Beta-receptor stimula-
tion is a mediator of coronary vasodilation (19). and systemic 
beta-blockade has been shown to decrease coronary artery 
caliber (20) and coronary blood flow (21) in both normal and 
atherosclerotic segments. Increased coronary artery vaso-
motor tone does not necessarily result in greater ischemia, 
however, and may. in some patients, be beneficial by main-
taining an even distribution of transmural blood flow (22). 
This paradox may explain our variable ischemia response to 
metoprolol during mental stress. Further work directly eval-
uating beta-blockade effects on coronary luminal caliber, 
blood flow and ischemia induction simultaneously must be 
performed to explore this hypothesis. 
Task potency and study order effect. We found previously 
(1) that the personally relevant public speaking task, de-
signed to be emotionally arousing. was more potent than 
other mental tasks in inducing wall motion abnormalities in 
the laboratory. A potential limitation of this prior study 
design was the performance of this task after the other 
mental tasks were completed, Thus. we could not exclude 
the possibility that a task-ordering effect was responsible for 
our observations, perhaps related to an increasingly acti-
vated neuroendocrine axis. In the current study, therefore, 
we compared two task orders. one in which the mental 
arithmetic task was performed as the first task, and one in 
which it was performed as the last task, after public speak-
ing. In both orders, public speaking was the most potent 
task, confirming its independent potency as a mental stres-
sor. The frequency of abnormality during the mental arith-
metic task, however, was higher when it was performed last, 
suggesting a potential task-ordering effect. 
Because our study was designed to assess the effects of 
mental stress tasks during two separate periods, we were 
concerned about habituation to the mental tasks resulting in 
a study order effect that would mask or confound drug 
effects. For this reason, the tasks were adapted between the 
first and second testing periods. We evaluated the relative 
results when mental stress testing during placebo and meto-
prolol therapy was performed as the first or second test: with 
habituation. a lesser frequency of abnormality would be 
expected when the respective testing was performed as the 
second test. We found no significant differences in responses 
to placebo or metoprolol between study periods for any of 
the mental stress-induced changes, suggesting that habitua-
tion was not a significant factor in our study. In support of 
this observation. McKinney et a1. (23) also found that 
hemodynamic reactivity to serial mental stress testing is 
reproducible and stable over time. 
Limitations. Because our patient population was rela-
tively small, our subgroup analyses were limited, Moreover, 
our subgroup findings may represent random variation rather 
than true pathophysiologic differences due to our post priori 
subgroup analyses. Prospective evaluation of additional pa-
tients is needed to confirm these findings, The use of a fixed 
dose of metoprolol, rather than a titrated, optimal dose 
regimen designed to maximize ischemia reduction, may have 
contributed to an underestimation of metoprolol's efficacy, 
especially in light of the favorable effect noted among 
patients with abolition of exercise-induced ischemia. The 
preferential selection of hypertensive patients may limit 
generalization of these findings to normotensive patients 
with coronary artery disease (25). Previous work questioned 
the specificity of radionuclide ventriculographic wall motion 
abnormalities for detection of coronary artery disease (ische-
mia) in hypertensive patients. More recent evidence (26,27), 
however, suggests that false positive radionuc1ide ventricu-
lographic results appear to correlate with left ventricular 
hypertrophy, which was evident in only 2 (11 %) of our 
patients. one of whom had coronary artery disease docu-
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mented by arteriography. The other patient had a negative 
exercise test for wall motion abnormality. 
Clinical implications. Our results both confirm and ex-
tend previous observations regarding myocardial ischemia 
and beta-blockade therapy. A beta-blocker is an effective 
anti-ischemic medication for ischemia associated with high 
myocardial oxygen demand, as demonstrated by these and 
other exercise study results 00-12). Our mental stress 
results suggest that beta-blockade may have less effect on 
low heart rate-related ischemia, a finding recently described 
in a study using ambulatory Holter monitoring (7). Patients 
with beta-blockade worsening of low heart rate-related 
ischemia had a higher frequency of prior myocardial infarc-
tion, a finding analogous to that of Rainwater et al. (24), who 
demonstrated worsened exercise thallium scintigraphic find-
ings during propranolol therapy in patients with prior myo-
cardial infarction. Our results suggest that abolition of exer-
cise-induced ischemia by beta-blockade may be a predictor 
of improvement of mental stress-induced ischemia. 
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